X0306 4 2020-06-15 0 0001636050 Axovant Gene Therapies Ltd. AXGT 0001636975 Nassif David W. C/O AXOVANT GENE THERAPIES LTD. 11 TIMES SQUARE, 33RD FLOOR NEW YORK NY 10036 0 1 0 0 Principal Financial Officer Common Shares 2020-06-11 4 A 0 15060 0.00 A 24210 D Common Shares 2020-06-11 4 F 0 5266 3.25 D 18944 D Restricted Stock Units 2020-06-12 4 D 0 15060 0.00 D Common Shares 15060 15060 D Balance includes 9,150 shares of Common Stock owned by the reporting person prior to his appointment as a Section 16 officer but was not previously reported. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. 50% of the common shares underlying the restricted stock units vested on January 31, 2020 but settlement of such portion of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted. /s/ Alison Haggerty, Attorney-In-Fact 2020-06-15